← Eichor
Study identifier: NCT07726940 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS

Condition: Acute Respiratory Distress Syndrome (ARDS)  ·  Sponsor: Southeast University, China

PhaseN/A
Planned participants1776
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Acute respiratory distress syndrome (ARDS) poses a major threat to human health. Despite extracorporeal membrane oxygenation (ECMO) support, mortality among patients with ARDS remains high due to severe complications and suboptimal mechanical ventilation strategies. Elucidating the mechanisms underlying ECMO-related complications and lung injury repair, and establishing a precision intervention pathway covering the entire course of ECMO management, are urgent unmet needs for improving outcomes in ARDS patients and addressing major public health challenges. This project focuses on five key scientific questions: 1. How can moderate-to-severe ARDS be classified into distinct clinical-immune phenotypes, and what are the optimal therapeutic targets for each phenotype? 2. What are the molecular mechanisms underlying severe complications in ARDS patients receiving ECMO support? 3. Which key immune biomarkers are associated with clinical benefit from awake ECMO? 4. How should mechanical ventilation strategies be optimized in moderate-to-severe ARDS patients supported with ECMO? 5. How can a comprehensive, full-cycle ECMO management pathway be established for patients with moderate-to-severe ARDS? The project consists of five interrelated subprojects: Subproject 1. Construction of Clinical-Immune Phenotypes and Identification of Therapeutic Targets in Moderate-to-Severe ARDS Clinical phenotypes and longitudinal multidimensional biospecimens collected throughout the disease course …

This description comes directly from the study's public registry record.

Talk to the study team

yingzi Huang Yingzi,Huang  ·  18271428804  ·  yz_huang@126.com

Always discuss trial participation with your own doctor first.

Locations (39)

Beijing Anzhen Hospital, Capital Medical UniversityBeijing, Beijing Municipality, ChinaRecruiting
Fujian Provincial HospitalFuzhou, Fujian, ChinaRecruiting
Zhongda Hospital, Southeast UniversityNanjing, Jiangsu, ChinaRecruiting
Qilu Hospital of Shandong UniversityJinan, Shandong, ChinaRecruiting
Sichuan Provincial People's HospitalChengdu, Sichuan, ChinaRecruiting
The Second Affiliated Hospital, Zhejiang University School of MedicineHangzhou, Zhejiang, ChinaRecruiting
The Second Hospital of Jilin UniversityChangchun, ChinaNot Yet Recruiting
The First People's Hospital of ChenzhouChenzhou, ChinaRecruiting
The Second Affiliated Hospital of Dalian Medical UniversityDalian, ChinaNot Yet Recruiting
The First Affiliated Hospital of Guangzhou Medical UniversityGuangzhou, ChinaRecruiting
Hangzhou First People's Hospital, Westlake University School of MedicineHangzhou, ChinaNot Yet Recruiting
The First Affiliated Hospital of Harbin Medical UniversityHa’erbin, ChinaNot Yet Recruiting

+ 27 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07726940